摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(N-methylsulfamoyl)pentyl pivalate | 1338075-51-6

中文名称
——
中文别名
——
英文名称
5-(N-methylsulfamoyl)pentyl pivalate
英文别名
5-(Methylsulfamoyl)pentyl 2,2-dimethylpropanoate;5-(methylsulfamoyl)pentyl 2,2-dimethylpropanoate
5-(N-methylsulfamoyl)pentyl pivalate化学式
CAS
1338075-51-6
化学式
C11H23NO4S
mdl
——
分子量
265.374
InChiKey
RHUXNBZPHMEGJP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    17
  • 可旋转键数:
    9
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    80.8
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    5-bromo-8-methoxy-1,6-naphthyridine-7-carboxylic acid5-(N-methylsulfamoyl)pentyl pivalatecopper(I) oxide2,2'-联吡啶 作用下, 以 N-甲基吡咯烷酮 为溶剂, 生成 8-methoxy-5-((N-methyl-5-(pivaloyloxy)pentyl)sulfonamido)-1,6-naphthyridine-7-carboxylic acid
    参考文献:
    名称:
    Copper-Catalyzed C–N Coupling in the Synthesis of Integrase Inhibitors of Immunodeficiency Viruses
    摘要:
    This contribution describes the total synthesis of a complex macrocyclic integrase inhibitor, a key enzyme involved in the infection process of various immunodeficiency viruses. The key transformation of the synthetic strategy was the selective C-N coupling of a sulfonamide to a heteroaryl bromide in the presence of potentially competing amide and carbamate functionalities. The transformation was accomplished with CuI catalysis using bypiridine as the ligand in the presence of base and enabled a convergent approach to the target molecule.
    DOI:
    10.1021/op400228z
点击查看最新优质反应信息

文献信息

  • [EN] MACROCYCLIC INTEGRASE INHIBITORS<br/>[FR] INHIBITEURS DE L'INTÉGRASE MACROCYCLIQUE
    申请人:TIBOTEC PHARM LTD
    公开号:WO2011121105A1
    公开(公告)日:2011-10-06
    Compound having Formula (I) and pharmaceutically acceptable salts or solvates thereof, their pharmaceutical formulations and use as HIV inhibitors.
    具有化学式(I)的化合物及其药用盐或溶剂化合物,它们的药物配方以及作为HIV抑制剂的用途。
  • MACROCYCLIC INTEGRASE INHIBITORS
    申请人:Thuring Johannes Wilhelmus J.
    公开号:US20130035341A1
    公开(公告)日:2013-02-07
    Compound having formula I and pharmaceutically acceptable salts or solvates thereof, their pharmaceutical formulations and use as HIV inhibitors.
    化学式为I的化合物及其药学上可接受的盐或溶剂化物,它们的制药配方和用途是HIV抑制剂。
  • US8716293B2
    申请人:——
    公开号:US8716293B2
    公开(公告)日:2014-05-06
  • Copper-Catalyzed C–N Coupling in the Synthesis of Integrase Inhibitors of Immunodeficiency Viruses
    作者:Jinguan Lin、Ioannis N. Houpis、Renmao Liu、Youchu Wang、Jianqian Zhang
    DOI:10.1021/op400228z
    日期:2014.1.17
    This contribution describes the total synthesis of a complex macrocyclic integrase inhibitor, a key enzyme involved in the infection process of various immunodeficiency viruses. The key transformation of the synthetic strategy was the selective C-N coupling of a sulfonamide to a heteroaryl bromide in the presence of potentially competing amide and carbamate functionalities. The transformation was accomplished with CuI catalysis using bypiridine as the ligand in the presence of base and enabled a convergent approach to the target molecule.
查看更多